Olaparib API

Holiness Pharmaceutical is a trusted and leading manufacturer and Pharmaceutical API exporter of Olaparib API in IP, BP, and USP grades, supplying premium Anti-Cancer/ Oncology APIs with stringent regulatory compliance to pharmaceutical companies across 40+ countries. With advanced technical expertise in PARP inhibitor class anticancer molecules, we are recognized as one of the most reliable Olaparib bulk API suppliers from India for targeted therapy formulations used in ovarian, breast, prostate, and pancreatic cancer treatments.

Worldwide, Holiness Pharmaceutical is regarded among the most reputable Olaparib API manufacturers, known for delivering high assay purity, low genotoxic impurities, controlled polymorphic forms, exceptional stability data, and complete global regulatory documentation. Our specialization in oncology and high-potency APIs positions us as a preferred partner for formulation companies seeking a dependable Pharmaceutical API exporter.

Our state-of-the-art oncology API manufacturing facilities operate in full compliance with major international pharmaceutical quality frameworks including:
➡ DCGI, WHO-GMP, US-FDA aligned, and cGMP standards,
ensuring validated synthetic processes, strong impurity profiling, HPAPI safety practices, and pharmacopeial compliance for Olaparib API.

We export high-quality Olaparib and other oncology APIs from India to Asia, Africa, the Middle East, Europe, North America, South America, and CIS regions, supporting global manufacturers producing targeted anticancer therapies and advanced oral Anti-Cancer/ Oncology formulations. Holiness Pharmaceutical is widely trusted as a bulk Olaparib API supplier serving regulated and semi-regulated markets worldwide.

Holiness Pharmaceutical is among the industry's leading producers of APIs (Active Pharmaceutical Ingredients) and Intermediates, offering robust quality systems, high regulatory alignment, and consistent supply as a certified Pharmaceutical API exporter specializing in Anti-Cancer/ Oncology and HP API molecules.

Holiness Pharmaceutical Ltd is a fully integrated pharmaceutical company involved in the full lifecycle of API development — including R&D innovation, targeted therapy API synthesis, HPAPI handling, commercial-scale manufacturing, and worldwide distribution of APIs and intermediates.

Recognized globally as a trusted partner, Holiness Pharmaceutical stands among the top API manufacturers in India, supported by advanced technology platforms, rigorous QA/QC processes, and a rapidly expanding global supply network as a leading bulk API supplier for oncology actives.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.